# FDA Inspection 1265723 - Janssen Biotech, Inc. - March 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/317587af-5e93-4aec-9bc1-7f56a3da087b
Source feed: FDA_Inspections

> FDA Inspection 1265723 for Janssen Biotech, Inc. on March 10, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265723
- Company Name: Janssen Biotech, Inc.
- Inspection Date: 2025-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1276933 - 2025-07-29](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/0ecc31ca-e799-4909-bfc9-dcdfa484fbf5)
- [FDA Inspection 1276933 - 2025-07-29](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/889c4f59-5fa0-444a-a4c3-8875e41282ff)
- [FDA Inspection 1265723 - 2025-03-10](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/15f02987-a4b7-4429-814c-f118133cbef1)
- [FDA Inspection 1077487 - 2018-11-30](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/12c3c1fb-2358-4e43-a202-ba2efbf754f2)
- [FDA Inspection 1046499 - 2018-03-05](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/4135886d-b271-492a-8b05-81d78eba721b)

Company: https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d